• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与韩国轻症 COVID-19 患者病毒脱落延迟终止相关的因素。

Factors Associated with the Delayed Termination of Viral Shedding in COVID-19 Patients with Mild Severity in South Korea.

机构信息

Department of Internal Medicine, College of Medicine, Hanyang University, Seoul 04763, Korea.

Department of Internal Medicine, College of Medicine, Korea University, Seoul 02841, Korea.

出版信息

Medicina (Kaunas). 2020 Nov 29;56(12):659. doi: 10.3390/medicina56120659.

DOI:10.3390/medicina56120659
PMID:33260421
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7761510/
Abstract

: We aimed to analyze factors associated with the period of viral shedding in patients with confirmed COVID-19 who experienced only mild symptoms. : We conducted a multicenter retrospective study from three community treatment centers (CTCs) of South Korea. All patients included were admitted to the three centers before 31 March 2020. We collected data about clinical characteristics and the result of real-time reverse transcription polymerase chain reaction (RT-PCR). : Viral shedding was terminated within 32 days and 36 days in 75% and 90% of patients, respectively (range: 8-49 days). The mean period of viral shedding was 23.8 ± 8.7 days. In the multivariate Cox proportional hazards regression analysis, the existence of underlying comorbidities lowered the probability of the termination of viral shedding (HR = 0.561, 95% CI 0.388-0.812). Female sex and presence of COVID-19-associated symptoms also lowered the probability, but the significance was marginal. : The existence of underlying comorbidities was associated with delayed termination of viral shedding in COVID-19 patients with mild severity.

摘要

我们旨在分析仅出现轻度症状的确诊 COVID-19 患者病毒脱落期的相关因素。

我们进行了一项多中心回顾性研究,纳入了韩国的 3 家社区治疗中心(CTCs)的患者。所有纳入的患者均在 2020 年 3 月 31 日前入住这 3 家中心。我们收集了临床特征和实时逆转录聚合酶链反应(RT-PCR)结果的数据。

分别有 75%和 90%的患者(范围:8-49 天)的病毒脱落期在 32 天和 36 天内终止,病毒脱落的平均持续时间为 23.8±8.7 天。在多变量 Cox 比例风险回归分析中,基础合并症的存在降低了病毒脱落终止的概率(HR=0.561,95%CI 0.388-0.812)。女性和 COVID-19 相关症状的存在也降低了这种概率,但意义不大。

基础合并症的存在与 COVID-19 轻症患者病毒脱落期的延长有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1a/7761510/868038e0baf7/medicina-56-00659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1a/7761510/0700fd12bd94/medicina-56-00659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1a/7761510/888ee8d74a38/medicina-56-00659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1a/7761510/4532c0d1a90d/medicina-56-00659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1a/7761510/868038e0baf7/medicina-56-00659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1a/7761510/0700fd12bd94/medicina-56-00659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1a/7761510/888ee8d74a38/medicina-56-00659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1a/7761510/4532c0d1a90d/medicina-56-00659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1a/7761510/868038e0baf7/medicina-56-00659-g004.jpg

相似文献

1
Factors Associated with the Delayed Termination of Viral Shedding in COVID-19 Patients with Mild Severity in South Korea.与韩国轻症 COVID-19 患者病毒脱落延迟终止相关的因素。
Medicina (Kaunas). 2020 Nov 29;56(12):659. doi: 10.3390/medicina56120659.
2
Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.韩国社区治疗中心中无症状和有症状的 SARS-CoV-2 感染患者的临床病程和分子病毒脱落情况。
JAMA Intern Med. 2020 Nov 1;180(11):1447-1452. doi: 10.1001/jamainternmed.2020.3862.
3
Clinical Course of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease Admitted to Community Treatment Centers, South Korea.韩国社区治疗中心收治的无症状和轻症冠病患者的临床病程。
Emerg Infect Dis. 2020 Oct;26(10):2346-2352. doi: 10.3201/eid2610.201620. Epub 2020 Jun 22.
4
Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.真正无症状的 SARS-CoV-2 感染可能很少见:仔细访谈和随访的重要性。
J Korean Med Sci. 2020 Sep 21;35(37):e333. doi: 10.3346/jkms.2020.35.e333.
5
Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.持续的 SARS-CoV-2 RNA 脱落而无传染性证据:一项 COVID-19 患者的队列研究。
J Infect Dis. 2021 Oct 28;224(8):1362-1371. doi: 10.1093/infdis/jiab107.
6
Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.严重急性呼吸综合征冠状病毒 2 感染患者长期病毒排出的临床特征及相关因素:一项单中心 28 天研究。
J Infect Dis. 2020 Aug 17;222(6):910-918. doi: 10.1093/infdis/jiaa388.
7
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
8
Factors affecting duration of SARS-Cov-2 viral shedding in mildly symptomatic patients isolated in a community facility.影响社区医疗机构隔离的轻症 SARS-CoV-2 感染者病毒脱落持续时间的因素。
PLoS One. 2021 Sep 27;16(9):e0257565. doi: 10.1371/journal.pone.0257565. eCollection 2021.
9
Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19.新型冠状病毒肺炎患者病毒RNA持续阴性转换的相关因素
Int J Infect Dis. 2021 Apr;105:463-469. doi: 10.1016/j.ijid.2021.02.089. Epub 2021 Feb 27.
10
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.SARS-CoV-2 RNA 存在于 COVID-19 患者的粪便中。
J Med Virol. 2020 Jul;92(7):833-840. doi: 10.1002/jmv.25825. Epub 2020 Apr 25.

引用本文的文献

1
High prevalence of SARS-CoV-2 antibodies and low prevalence of SARS-CoV-2 RNA in cats recently exposed to human cases.最近接触过人感染病例的猫中,SARS-CoV-2 抗体的高流行率和 SARS-CoV-2 RNA 的低流行率。
BMC Vet Res. 2024 Jul 9;20(1):304. doi: 10.1186/s12917-024-04150-4.
2
Estimation of shedding time in laboratory-confirmed COVID-19 cases in South Africa: a population-based record linkage study, March-December 2020.南非基于人群的病例关联研究估算实验室确诊的 2019 冠状病毒病病例的脱落时间:2020 年 3 月至 12 月。
Pan Afr Med J. 2023 Sep 15;46:24. doi: 10.11604/pamj.2023.46.24.41047. eCollection 2023.
3
Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study.

本文引用的文献

1
Persistent severe acute respiratory syndrome coronavirus 2 detection after resolution of coronavirus disease 2019-associated symptoms/signs.持续检测到严重急性呼吸综合征冠状病毒 2 后,新冠病毒 2019 相关症状/体征已解决。
Korean J Intern Med. 2020 Jul;35(4):793-796. doi: 10.3904/kjim.2020.203. Epub 2020 Jun 19.
2
Risk factors for viral RNA shedding in COVID-19 patients.COVID-19 患者病毒 RNA 脱落的风险因素。
Eur Respir J. 2020 Jul 2;56(1). doi: 10.1183/13993003.01190-2020. Print 2020 Jul.
3
Estimation of Unreported Novel Coronavirus (SARS-CoV-2) Infections from Reported Deaths: A Susceptible-Exposed-Infectious-Recovered-Dead Model.
对有症状 COVID-19 患者中 SARS-CoV-2 的持续病毒脱落及其相关因素的前瞻性研究。
BMC Infect Dis. 2021 Dec 27;21(1):1282. doi: 10.1186/s12879-021-07002-w.
4
Using the IPcase Index with Inflection Points and the Corresponding Case Numbers to Identify the Impact Hit by COVID-19 in China: An Observation Study.使用带有拐点的 IPcase 指数和相应的病例编号来识别 COVID-19 在中国造成的影响:一项观察性研究。
Int J Environ Res Public Health. 2021 Feb 18;18(4):1994. doi: 10.3390/ijerph18041994.
根据报告的死亡病例估算未报告的新型冠状病毒(SARS-CoV-2)感染情况:一种易感-暴露-感染-康复-死亡模型
J Clin Med. 2020 May 5;9(5):1350. doi: 10.3390/jcm9051350.
4
Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients.无症状感染者和有症状前患者体内 SARS-CoV-2 的病毒动力学。
Int J Infect Dis. 2020 Jun;95:441-443. doi: 10.1016/j.ijid.2020.04.083. Epub 2020 May 4.
5
Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19.与 COVID-19 住院患者病毒 RNA 阴转相关的因素。
Sci Total Environ. 2020 Aug 1;728:138812. doi: 10.1016/j.scitotenv.2020.138812. Epub 2020 Apr 22.
6
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.2020 年 1 月至 3 月在中国浙江省感染 SARS-CoV-2 的患者的病毒载量动态和疾病严重程度:回顾性队列研究。
BMJ. 2020 Apr 21;369:m1443. doi: 10.1136/bmj.m1443.
7
Profile of RT-PCR for SARS-CoV-2: A Preliminary Study From 56 COVID-19 Patients.新型冠状病毒2019(SARS-CoV-2)逆转录聚合酶链反应(RT-PCR)分析:来自56例2019冠状病毒病(COVID-19)患者的初步研究
Clin Infect Dis. 2020 Nov 19;71(16):2249-2251. doi: 10.1093/cid/ciaa460.
8
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
9
Viral dynamics in mild and severe cases of COVID-19.新冠肺炎轻症和重症病例中的病毒动力学
Lancet Infect Dis. 2020 Jun;20(6):656-657. doi: 10.1016/S1473-3099(20)30232-2. Epub 2020 Mar 19.
10
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).大量未记录的感染使新型冠状病毒(SARS-CoV-2)迅速传播。
Science. 2020 May 1;368(6490):489-493. doi: 10.1126/science.abb3221. Epub 2020 Mar 16.